Lind Global Macro Fund LP 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Lind Global Macro Fund LP 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
5:01 pm
Sale		 2021-12-31 13G BriaCell Therapeutics Corp.
BCTX		 Lind Global Macro Fund LP 2,443
0.200%		 -35,063decrease
(-93.49%)		 Filing
2021-02-26
5:02 pm
Purchase		 2021-02-26 13G BriaCell Therapeutics Corp.
BCTX		 Lind Global Macro Fund LP 37,507
9.900%		 37,507increase
(New Position)		 Filing